2010
DOI: 10.1007/s10439-010-0218-9
|View full text |Cite
|
Sign up to set email alerts
|

From Cleanroom to Desktop: Emerging Micro-Nanofabrication Technology for Biomedical Applications

Abstract: This review is motivated by the growing demand for low-cost, easy-to-use, compact-size yet powerful micro-nanofabrication technology to address emerging challenges of fundamental biology and translational medicine in regular laboratory settings. Recent advancements in the field benefit considerably from rapidly expanding material selections, ranging from inorganics to organics and from nanoparticles to self-assembled molecules. Meanwhile a great number of novel methodologies, employing off-the-shelf consumer e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
48
0

Year Published

2011
2011
2019
2019

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 64 publications
(50 citation statements)
references
References 218 publications
(365 reference statements)
2
48
0
Order By: Relevance
“…They have direct applications such as prototype generation [1,27], flexible electronics [193,369], and point-of-care diagnostics [123,433]. Issues that need to be explored further include scalability, metallization, consistence, and compatibility due to nonstandard fabrication and material processing, as well as integration with large-scale systems [315].…”
Section: Novel Trends From Cleanroom To Desktopmentioning
confidence: 99%
“…They have direct applications such as prototype generation [1,27], flexible electronics [193,369], and point-of-care diagnostics [123,433]. Issues that need to be explored further include scalability, metallization, consistence, and compatibility due to nonstandard fabrication and material processing, as well as integration with large-scale systems [315].…”
Section: Novel Trends From Cleanroom To Desktopmentioning
confidence: 99%
“…Most biomarker testing is currently taking place at centralized dedicated laboratories using large, automated analyzers, which increases both the analytical times and their associated costs. Accordingly, there is an urgent need in the clinical laboratory for smaller, faster, and cheaper devices in order to make analytical results available with high accuracy at the patient's bedside (point-of-care diagnostics) [90,91]. The development of devices based on miniaturized microfluidic technologies (e.g., LC or CE in conventional format or in microchip format) coupled to immunological platforms is one of the most promising ways to solve some of the problems concerning the increasing need to develop highly sensitive, fast, and economic methods of analysis in medical diagnostics (Table 1) [92][93][94].…”
Section: Iace For the Quantification Of Predictive Biomarkersmentioning
confidence: 99%
“…16 CTS nanoparticles (CTS-NP) have also received much attention as the carriers for various drugs. 17 However, the effects of CTS microparticles (CTS-MP) and CTS-NP on antiobesity have not been reported.…”
Section: Introductionmentioning
confidence: 99%